Rare RAS mutations may not undermine cetuximab benefit in colorectal cancer
A small retrospective study found that metastatic colorectal cancer patients whose tumors carried only rare, non-hotspot RAS or RAF mutations ...
Tag: RAS mutations
Targeted RAS Drug Shows Survival Benefit Across Advanced Pancreatic Cancer Subgroups
A subgroup analysis of the phase 3 RASolute 302 trial presented at ESMO found the targeted RAS inhibitor daraxonrasib extended ...
Two Prestigious Grants Empower Young Investigator to Advance Blood Cancer Research
In recent years, the scientific community has placed a robust emphasis on a family of genes known as RAS due ...
POPULAR NEWS
-
CRISPR Beta-Cell Regeneration Shows Early Promise for Long-Term Diabetes Management
-
Sudan Study Reveals Gaps in Kidney Stone Prevention Care
-
Machine Learning Model Predicts Pediatric Sepsis Risk Using Routine Clinical Indicators
-
ChatMPC Integrates Natural Language Processing with Predictive Control for Autonomous Driving